IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.